Zydus gets rights to gastro drug Actibile

India’s Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare (BOM: 532321), has entered into a definitive agreement to acquire Actibile (ursodeoxycholic acid) from Albert David Limited (ADL).

The brand falls in the gastroenterology segment and is used for dissolving gall bladder stones. The deal will be financed through internal accruals. No further terms of the accord were revealed.

Speaking on the development, chairman and managing director of the group Pankaj Patel said: “The gastrointestinal segment has been one of our core focus segments and we have been working with the medical fraternity to serve patient needs better. I believe that this acquisition will strengthen our portfolio of brands and leverage our equity in this key segment.”